| Name | BTB01303 |
|---|
| Description | BTB01303 is a (glutamate release) inhibitor. Cancer cells release high levels of (glutamate), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C15H11Cl2NO3 |
|---|---|
| Molecular Weight | 324.16 |